Bharglob 16.5% Injection
Bharglob 16.5% Injection is an immunoglobulin (Ig) therapy used to treat patients with primary and secondary immunodeficiencies and certain autoimmune inflammatory conditions. It contains Human Normal Immunoglobulin (16.5%), which supports the immune system by supplying essential antibodies that help fight infections and modulate immune responses.
Features:
-
Contains Human Normal Immunoglobulin for passive immunity
-
Used in both immunodeficiency and autoimmune conditions
-
Suitable for intravenous or subcutaneous administration
-
Produced from pooled human plasma
-
High purity and virus-inactivated for safety
-
Administered under medical supervision only
-
Offers both anti-infective and immunomodulatory benefits
Technical Specification |
|
---|
- 1 ml per vial
-
Boosts immune protection in patients with antibody deficiencies
-
Reduces frequency and severity of infections
-
Helps modulate autoimmune responses
-
Proven efficacy in neurological and vascular inflammatory diseases
-
Safe for pediatric, elderly, and immunocompromised patients when monitored
-
Reduces disease progression in CIDP and neuropathies
-
Can improve platelet counts in immune thrombocytopenia